Welcome to our dedicated page for Paychex SEC filings (Ticker: PAYX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Paychex, Inc. filings document formal disclosures for its human capital management business, including quarterly operating results furnished on Form 8-K, credit facility amendments, capital-return authorizations, and governance changes involving directors and senior officers.
The company's proxy materials and annual-meeting reports address board elections, executive compensation votes, auditor ratification, committee matters, and stockholder voting outcomes. Its filings also describe common-stock repurchase authority, revolving credit facilities, covenant changes, and formal reporting for payroll, HCM, HR Solutions, PEO, ASO, benefits, retirement, and insurance services.
Paychex, Inc. (PAYX) – Form 144 notice of proposed sale
The filing discloses that an affiliate intends to sell up to 21,642 common shares of Paychex through Merrill Lynch (9128 Strada Pl, Naples FL) on or after 14 July 2025. Based on the stated aggregate market value of $3,114,070.73, the planned sale represents roughly 0.006 % of the 360,190,668 shares outstanding—an immaterial proportion of the float. The shares were originally gifted by Martin Mucci on 11 July 2025, reflecting underlying donations made between 2007 and 2013. No other Paychex shares have been sold by this filer in the past three months, and the signer affirms no knowledge of undisclosed adverse information.
Rule 144 filings are routine compliance documents that allow insiders or affiliates to sell restricted or control stock, provided they meet volume, timing and manner-of-sale conditions. Given the modest transaction size relative to Paychex’s market capitalization, the notice is unlikely to exert meaningful pressure on the share price or alter the company’s fundamental outlook.
Paychex Inc. (PAYX) filed a Form 144 disclosing a proposed disposition of 97,526 common shares via Fidelity Brokerage Services, tentatively dated 07/10/2025. The shares carry an aggregate market value of $14.16 million and were obtained through a cash-settled stock-option exercise on the same date. No insider sales were reported during the preceding three-month period. With 360,190,668 shares outstanding, the transaction equates to roughly 0.03 % of the company’s float, indicating limited prospective pressure on the stock’s supply.
Paychex, Inc. (PAYX) filed an amended Form 8-K/A to update Item 9.01 in connection with its previously announced acquisition of Paycor HCM, Inc. completed on April 14, 2025. The amendment supplies the historical financial statements of Paycor and related pro forma information that were not included in the original April 14 filing.
Financial statements provided:
- Audited consolidated statements of Paycor for the fiscal year ended June 30, 2024 (incorporated by reference from Paycor’s Form 10-K).
- Unaudited consolidated statements for the quarter ended December 31, 2024 (from Paycor’s Form 10-Q).
Pro forma data: Exhibit 99.1 presents unaudited pro forma condensed combined statements of income for the six-month period ended November 30, 2024 and fiscal year ended May 31, 2024, as if the merger had closed on June 1, 2023, plus a pro forma combined balance sheet as of November 30, 2024 assuming the merger closed on that date. These figures are provided solely for illustrative purposes and are not intended to forecast future results.
Additional exhibits: Exhibit 23.1 supplies the consent of Ernst & Young LLP as Paycor’s independent auditor, and Exhibit 104 is the interactive XBRL cover page. No other sections of the original 8-K have been changed.
The filing ensures Paychex meets SEC reporting requirements for significant business combinations and gives investors the first look at how Paycor’s results may influence consolidated PAYX performance.